Didem Tezen | Medicine and Dentistry | Best Researcher Award

Dr. Didem Tezen | Medicine and Dentistry | Best Researcher Award

Istanbul University- Cerrahpasa, Cerrahpasa Faculty of Medicine, Turkey

Dr. Didem Tezen is a dedicated neurologist and researcher with a strong academic background and extensive experience in clinical neurology. She has contributed significantly to the field through her research on neuromuscular disorders, dementia, movement disorders, and neurogenetics. With multiple publications in reputable journals, she has demonstrated expertise in both clinical and molecular neuroscience. Dr. Tezen’s research focuses on the genetic and biochemical mechanisms underlying neurological diseases, aiming to advance diagnostic and therapeutic approaches. She has worked at prestigious institutions, including Istanbul University-Cerrahpaşa and Bakırköy Dr. Sadi Konuk Training and Research Hospital, and currently serves at Oltu State Hospital in Erzurum, Turkey. Her work is highly regarded for its impact on understanding rare neuromuscular syndromes, neuroinflammatory pathways, and neurodegeneration. She actively collaborates with leading experts in neurology and has played a key role in pioneering studies on biomarkers for dementia and genetic mutations in movement disorders. Dr. Tezen’s commitment to scientific discovery and her clinical expertise make her a valuable contributor to the field of neurology. Her growing international presence and dedication to translational research place her among the emerging leaders in neurological research and patient care.

Professional Profile

Education

Dr. Didem Tezen has pursued a distinguished academic journey in medicine and neurology, building a solid foundation for her research and clinical practice. She completed her medical education at Istanbul University, Istanbul Faculty of Medicine from 2011 to 2017, where she developed her fundamental medical knowledge and clinical skills. After graduating, she advanced her expertise by specializing in neurology at Istanbul University-Cerrahpaşa, Cerrahpaşa Faculty of Medicine, between 2018 and 2024. This rigorous residency program provided her with extensive experience in managing a wide range of neurological conditions, including neurodegenerative diseases, neuromuscular disorders, and cerebrovascular diseases. During her studies, she actively participated in clinical research projects and collaborated with experienced faculty members, allowing her to gain practical knowledge in neurophysiology, neuroimaging, and genetic neurology. Her educational background has played a crucial role in shaping her research interests, particularly in biomarker discovery, genetic analysis, and neuroinflammatory mechanisms in neurological disorders. Currently, she continues to apply her knowledge and expand her expertise as a practicing neurologist, while also engaging in ongoing research in her field. Her academic achievements and commitment to lifelong learning highlight her dedication to advancing neurological science and patient care.

Professional Experience

Dr. Didem Tezen has accumulated extensive clinical and research experience throughout her career in neurology. She began her professional journey at Bakırköy Dr. Sadi Konuk Training and Research Hospital, where she worked from 2017 to 2018, gaining firsthand experience in diagnosing and treating a variety of neurological conditions. This period provided her with essential clinical skills and exposure to neurology emergencies and complex neurological disorders. From 2018 to 2024, she further honed her expertise at Istanbul University-Cerrahpaşa, Cerrahpaşa Faculty of Medicine, Neurology Department, where she was involved in both clinical neurology and research. During this time, she contributed to several groundbreaking studies focusing on neurodegenerative diseases, neuromuscular disorders, and molecular neurology. She collaborated with esteemed researchers and specialists in neurophysiology, genetics, and electrophysiology, leading to several high-impact publications. As of 2024, Dr. Tezen has been serving as a neurologist at Oltu State Hospital in Erzurum, Turkey, where she continues to provide specialized care to patients with complex neurological disorders. Her clinical expertise, combined with her strong research background, allows her to integrate the latest scientific advancements into patient treatment, making her a highly valued physician and researcher in the field of neurology.

Research Interests

Dr. Didem Tezen’s research interests are primarily focused on the genetic and biochemical mechanisms of neurological diseases, aiming to improve both diagnostic and therapeutic approaches. One of her key areas of interest is neurodegeneration, particularly the role of biomarkers and neuroinflammatory pathways in dementia and Alzheimer’s disease. Her research has explored the clinical significance of YKL-40, VILIP-1, and inflammatory cytokines in neurodegenerative disorders, shedding light on their potential use as biomarkers for disease progression. She is also deeply engaged in studying neuromuscular diseases, with a focus on congenital myasthenic syndromes, hereditary polyneuropathies, and motor neuron diseases. Her investigations into genetic mutations associated with these disorders have provided critical insights into their pathophysiology. Additionally, she has contributed to research on movement disorders, examining rare cases of ADCY5 gene mutations and cerebrotendinous xanthomatosis. Dr. Tezen is also interested in clinical neurophysiology, particularly the application of electromyography (EMG) and nerve conduction studies in diagnosing neuromuscular and movement disorders. Her multidisciplinary approach, integrating genetics, neuroinflammation, and electrophysiology, positions her as a forward-thinking researcher in the field of neurology.

Research Skills

Dr. Didem Tezen possesses a diverse set of research skills that enable her to conduct high-quality scientific investigations in neurology. She is proficient in neurogenetics, with expertise in analyzing genetic mutations related to neuromuscular diseases and movement disorders. Her ability to integrate molecular genetics and clinical findings has significantly contributed to understanding rare neurological conditions. She is also skilled in biomarker research, particularly in the context of dementia and neurodegeneration. Her experience in measuring serum biomarkers, neuroinflammatory markers, and neurodegenerative proteins has advanced the field’s understanding of disease progression and potential treatment targets. In clinical neurophysiology, she has expertise in performing and interpreting electrophysiological tests, such as EMG and nerve conduction studies, which are essential for diagnosing neuromuscular disorders. Additionally, her research involves advanced neuroimaging techniques, including MRI analysis of brain volume changes in dementia patients. Her ability to design clinical studies, analyze statistical data, and collaborate with interdisciplinary teams further enhances her research capabilities. Her strong academic writing skills have also enabled her to publish multiple research papers in peer-reviewed journals, reinforcing her reputation as an accomplished researcher.

Awards and Honors

Dr. Didem Tezen has been recognized for her outstanding contributions to neurology research through several awards and honors. She has received institutional recognition for her work in biomarker discovery and neurogenetics, contributing to a deeper understanding of neurodegenerative and neuromuscular disorders. Her research on biomarkers in dementia and neuroinflammatory pathways has been highly regarded in neurology conferences and academic circles. She has also played a key role in multi-disciplinary research teams that have advanced the field of neuromuscular genetics. In addition to her scientific achievements, Dr. Tezen’s clinical excellence and commitment to patient care have earned her commendations from senior neurologists and faculty members. Her dedication to both research and clinical neurology sets her apart as a well-rounded physician-scientist. With her growing body of work and increasing international presence, she is poised to receive further recognition for her contributions to neurology and neuroscience research in the years to come.

Conclusion

Dr. Didem Tezen is a highly accomplished neurologist and researcher with a strong background in neuromuscular disorders, neurodegeneration, and neurogenetics. Her extensive research output, clinical expertise, and multidisciplinary approach make her a valuable asset to the field of neurology. Her contributions to biomarker discovery, genetic analysis, and electrophysiology have advanced our understanding of neurological diseases, earning her recognition among peers. While she has already established a strong foundation, further expanding her international collaborations, securing research funding, and increasing first-author publications could elevate her to greater scientific prominence. Overall, Dr. Tezen is a deserving candidate for the Best Researcher Award, and her dedication to scientific excellence will continue to have a significant impact on neurology research and patient care.

Scientific Activities

  1. Tezen D, Koçhan Kızılkılıç E, Akkan Suzan A, et al. 2025.

    • Correlation between serum YKL-40 and VILIP 1 levels and brain volume in dementia patients.
  2. Tezen D, Khojakulov Z, Gündüz A, Deymeer F, Demirbilek V, Başak AN. 2024.

    • Clinical, electrophysiological, and genetic analysis of a family with two rare neuromuscular disorders: congenital myasthenic syndrome and hereditary polyneuropathy.
  3. Tezen D, Kızılkılıç EK, Erener N, Khojakulov Z, Demirbilek V, Başak AN. 2025.

    • Experience with salbutamol treatment in a family with congenital myasthenia due to CHRNE mutation.
  4. Tezen D, Savrun F. 2023.

    • Alt Motor Nöron Hastalıkları, in Türkiye Klinikleri Nöroloji Özel Sayı-Motor Nöron Hastalıkları, edited by Nurten Uzun Adatepe.
  5. Gulmammadli N, Konukoğlu D, Merve Kurtuluş E, Tezen D, Ibrahim Erbay M, Bozluolçay M. 2022.

    • Serum Sirtuin-1, HMGB1-TLR4, NF-KB and IL-6 levels in Alzheimer’s: The Relation Between Neuroinflammatory Pathway and Severity of Dementia.
  6. Tezen D, Gunduz A, Erdemir Kiziltan M, Yalcinkaya C, Kiziltan G. 2022.

    • ADCY5 gene mutation: a case report.
  7. Tezen D, Şimşir G, Çokar Ö, Demirbilek V, Başak AN, Yapıcı Z. 2022.

    • Four Turkish families with hyperekplexia: A missense mutation and the exon 1-7 deletion in the GLRA1 gene.
  8. Aktuglu Zeybek C, Gunduz A, Enver EO, Tezen D, Kiykim E, Kızıltan ME. 2020.

    • Movement disorders in the early-diagnosed cerebrotendinous xanthomatosis: An electrophysiological study.
  9. Benbir Şenel G, Tezen D, Tekgül Ş, Başak AN. 2020.

    • Co-existence of Mutations in PRRT2 and ABCC6 Genes in a Turkish Family.

Maksym Pikul | Medicine and Dentistry | Best Researcher Award

Dr. Maksym Pikul | Medicine and Dentistry | Best Researcher Award

Scientific Co-worker at University Hospital Cologne, Germany

Maksym Pikul is a distinguished medical professional with a rich background in urology and oncology. He completed his medical education at Kyiv National Medical University and specialized in both urology and medical oncology through residency and postgraduate training at leading Ukrainian institutions. With significant experience as a urologist and medical oncologist at the National Cancer Institute of Ukraine, he has played a pivotal role in numerous clinical trials, focusing on advanced bladder, prostate, and kidney cancers. Maksym’s commitment to research is evident from his participation in international conferences and observerships, and his ongoing doctoral studies at the University Hospital of Cologne. Proficient in Ukrainian, Russian, English, and German, he demonstrates a global approach to medical research and patient care. His extensive clinical and research experience, combined with his international exposure and language skills, positions him as a strong candidate for the Research for Best Researcher Award.

Profile

Education

Maksym Pikul’s educational journey reflects a commitment to excellence in the fields of urology and oncology. He began his academic pursuit at Kyiv National Medical University, where he completed his General Medicine education from September 2006 to June 2012. Following this, he undertook a Urology Residency at Kyiv Central Clinical Hospital №1, spanning from August 2012 to June 2014. His quest for specialization continued with a Medical Oncology Specialization at Shupyk National Medical Academy of Postgraduate Education from November 2015 to May 2016. Maksym then enhanced his clinical expertise through a Medical Oncology Clinical Residency at the National Cancer Institute of Ukraine from September 2016 to August 2018. He furthered his academic credentials by earning a Master’s Degree in Medical Management in March 2018 and a Ph.D. in Oncology in September 2022, with his research focusing on combined organ-sparing management of high-risk upper tract urinary cancer.

Professional Experience

Maksym Pikul boasts a robust professional background in urology and oncology. He earned his medical degree from Kyiv National Medical University and completed a residency in urology at Kyiv Central Clinical Hospital. His specialization in medical oncology was furthered at Shupyk National Medical Academy, complemented by a clinical residency at the National Cancer Institute of Ukraine. Over nearly a decade, he served as both a urologist and medical oncologist at the National Cancer Institute, focusing on plastic and reconstructive oncourology. Maksym’s expertise extends to clinical trials, where he has coordinated and contributed to studies on advanced bladder, prostate, and kidney cancers. Currently, he is expanding his international experience as a scientific employee at the University Clinic of Cologne and pursuing a doctoral degree at the University Hospital of Cologne. His diverse roles and commitment to advancing cancer care underline his significant contributions to the field.

Research Interest

Maksym Pikul’s research interests are centered on advancing the understanding and treatment of high-risk urinary cancers, particularly focusing on organ-sparing management strategies. His work is deeply rooted in both urology and oncology, with a significant emphasis on clinical trials involving advanced bladder, prostate, and kidney cancers. Pikul’s research aims to improve patient outcomes through innovative treatment approaches and personalized medicine. His Ph.D. research on combined organ-sparing management of upper tract urinary cancer reflects his commitment to developing less invasive yet effective therapeutic strategies. Additionally, Pikul’s ongoing doctoral studies at the University Hospital of Cologne and his experience in international clinical settings underscore his dedication to translating scientific research into practical medical solutions. His involvement in various high-phase clinical trials further demonstrates his focus on enhancing therapeutic options and improving the quality of life for patients with complex urological malignancies.

Research Skills

Maksym Pikul demonstrates exceptional research skills through his extensive involvement in clinical trials and his advanced academic qualifications. His expertise encompasses designing and coordinating studies, including managing advanced-stage bladder, prostate, and kidney cancer trials. As a principal investigator designee, he has effectively led trials from inception to completion, ensuring adherence to Good Clinical Practice (GCP) and regulatory standards. His research capabilities are further evidenced by his Ph.D. in Oncology, focusing on high-risk upper tract urinary cancer, which underscores his in-depth knowledge and specialized skills. Maksym has presented his research at numerous international conferences, showcasing his ability to communicate complex findings effectively. His experience with electronic medical record systems and his multilingual proficiency enhance his ability to collaborate with diverse research teams and access a broad spectrum of scientific resources. Overall, his research skills reflect a strong commitment to advancing medical knowledge and improving patient outcomes.

Award and Recognition

Maksym Pikul has garnered significant recognition for his contributions to the fields of urology and oncology. His dedication to advancing medical practice through research has been acknowledged at numerous international forums, where he has presented his work at prominent conferences such as the EAU Congress and the ASCO GU Conference. His research into high-risk upper tract urinary cancer has been well-regarded, showcasing his commitment to pioneering new treatments and improving patient outcomes. Maksym’s role in managing multiple clinical trials, including advanced stages of bladder, prostate, and kidney cancer, highlights his expertise and leadership in clinical research. His active participation in global scientific communities and ongoing education further exemplify his dedication to advancing medical knowledge and practice. These achievements reflect his significant impact on the field and underscore his suitability for prestigious awards and recognition in his area of expertise.

Conclusion

Maksym Pikul is a highly qualified candidate for the Research for Best Researcher Award, showcasing a robust combination of clinical expertise, research experience, and international engagement. His contributions to clinical trials and oncology research are notable, but to enhance his candidacy, he should focus on increasing his publication record, showcasing the impact of his research, and highlighting any leadership or mentorship roles. Strengthening these areas will provide a more comprehensive view of his contributions and impact in the field of urology and oncology.

Publication Top Notes

  1. Title: Comparison of Aggressiveness in Central Versus Peripheral T1a Clear-Cell Renal Cell Carcinoma
    • Authors: Semko, S.L., Voylenko, O.A., Pikul, M.V., Stakhovsky, E.O., Hrechko, B.
    • Year: 2024
    • Journal: Urologic Oncology: Seminars and Original Investigations
    • Volume: 42
    • Issue: 2
    • Pages: 31.e9–31.e15
    • Citations: 1
  2. Title: Advantages of Organ-Sparing Treatment Approaches in Metastatic Kidney Cancer
    • Authors: Vitruk, I., Voylenko, O., Stakhovsky, O., Koshel, D., Stakhovsky, E.
    • Year: 2023
    • Journal: Journal of Cancer Research and Clinical Oncology
    • Volume: 149
    • Issue: 7
    • Pages: 3131–3137
    • Citations: 1
  3. Title: Modification of Fast-Track Surgery During Partial Nephrectomy
    • Authors: Voylenko, O.A., Pikul, M.V., Semko, S.L., Vitruk, I.V., Stakhovskyi, E.O.
    • Year: 2023
    • Journal: Ukrainian Journal of Nephrology and Dialysis
    • Volume: 80
    • Issue: 4
    • Pages: 24–33
  4. Title: Efficacy of Combined Organ-Sparing Management of Invasive Upper Urinary Tract Urothelial Carcinoma
    • Authors: Pikul, M.V., Stakhovsky, E.O.
    • Year: 2023
    • Journal: Central European Journal of Urology
    • Volume: 76
    • Issue: 2
    • Pages: 116–122
  5. Title: Effects of Tumor and Concomitant Pathology on Morpho-Functional Changes in the Kidneys
    • Authors: Krotevych, M., Trokhymych, S.S., Koshubarova, M.V., Stakhovskyi, E.O., Pasichnyk, S.M.
    • Year: 2022
    • Journal: Experimental Oncology
    • Volume: 44
    • Issue: 1
    • Pages: 166–172
  6. Title: Evaluation of Response to Tyrosine Kinase Inhibitors in Renal Cell Carcinoma Patients Based on Expression of miR-99b, -144, -210, -222, -302a, and -377 in Tumor Tissue
    • Authors: Vitruk, Yu.V., Semko, S.L., Voylenko, O.A., Stakhovsky, E.O., Rossylna, O.V.
    • Year: 2021
    • Journal: Experimental Oncology
    • Volume: 43
    • Issue: 2
    • Pages: 98–103
    • Citations: 1
  7. Title: Efficacy of Neoadjuvant Targeted Therapy in Treatment of Patients with Localized Clear-Cell Renal Cell Carcinoma
    • Authors: Voylenko, O.A., Stakhovsky, O.E., Vitruk, I.V., Semko, S.L., Stakhovsky, E.O.
    • Year: 2021
    • Journal: Advances in Urology
    • Volume: 2021
    • Article ID: 6674637
    • Citations: 6
  8. Title: Quality of Life in Patients After Radical Cystectomy with Modified Ureterocutaneostomy and Bricker Urinary Diversion
    • Authors: Stakhovskyi, O.E., Semko, S.L., Pikul, M.V., Vitruk, I.V., Stakhovsky, E.O.
    • Year: 2020
    • Journal: Experimental Oncology
    • Volume: 42
    • Issue: 3
    • Pages: 224–227
    • Citations: 3
  9. Title: Transperitoneal Uretercutaneostomy with Use of Mesosigmoid Colon Peritoneum in Patients with Bladder Cancer After Radical Cystectomy
    • Authors: Stakhovskyi, O.E., Pikul, M.V., Semko, S.L., Grechko, B.V., Stakhovsky, E.O.
    • Year: 2020
    • Journal: Wiadomosci Lekarskie (Warsaw, Poland: 1960)
    • Volume: 73
    • Issue: 5
    • Pages: 988–993
  10. Title: A Case of Synchronous Bilateral Calyx Urothelial Carcinoma: Combined Treatment Approach
    • Authors: Semko, S., Pikul, M., Voylenko, O., Vitruk, Yu., Stakhovsky, E.
    • Year: 2019
    • Journal: Experimental Oncology
    • Volume: 41
    • Issue: 1
    • Pages: 76–79